Summary The Drosophila ras2 promoter region exhibits bidirectional activity, as has been demonstrated for the human c-Ha-rasl and the mouse c-Ki-ras. Here we address a unique case of ras regulation, as Drosophila ras2 provides the only example to date in which the flanking gene (rop) and its product have been isolated. A linking mechanism of control suggests a mutual interaction between the two gene products. Our studies indicate that the Drosophila ras2 promoter region shares with the human c-Ha-rasl promoter a CACCC box and an AP-l-like sequence. A 14 bp promoter fragment which holds a CACCC element is demonstrated to interact with a specific transcription factor (factor B). This CACCC promoter element represents a stretch of imperfect palindrome. We present evidence that this factor can form a complex with another specific DNA-binding protein (factor A). The binding sites (A + B) for these protein factors are essential for 95% expression of both genes flanking the promoter (ras2 and rop). Region A consists of four overlapping consensus sequences: a TATA-like element, a DSE-like motif (the core sequence of the serum response element), a DRE octamer, which has been shown to play a role in cell proliferation, and a 5 bp direct repeat representing the GATA consensus sequence. Factor A has a very weak affinity to the full promoter region, but when complexed with factor B binding efficiency is enhanced. We also show that alterations of DNA-protein binding specificities can be achieved by supplementing the growth media with different sera.
The ras superfamily consists of more than 60 genes encoding small GTPases that can switch from an inactive (GDPbound) state to an active (GTP-bound) state (Hall, 1990) . Although the best-known members are the ras protooncogenes (Barbacid, 1987) , the precise function of Ras proteins remain unclear, though the prevailing view is that they act as transducers of mitogenic signals (Chardin, 1991; Egan et al., 1993) . Their involvement in cellular differentiation and cellular proliferation has been reviewed elsewhere (Barbacid, 1987; Bar-sagi & Feramisco, 1985; Birchmeier et al., 1985; Feramisco et al., 1984; Hagag et al., 1986; McCormick, 1989) . ras oncogenes are the most frequent group of oncogenes so far identified in human cancers (Barbacid, 1987; Bos, 1988) . A very high proportion -up to 30% -of a variety of human tumours, including carcinomas, melanomas, seminomas, leukaemias, sarcomas and neuroblastomas, contain activated ras oncogenes (Almoguera et al., 1988;  Barbacid, 1990; Bos et al., 1987; Bos, 1989;  Downward, 1990; Forrester et al., 1987; Spandidos, 1987) . ras genes can acquire transforming properties by qualitative and quantitative mechanisms (Alitalo, 1984; Chang et al., 1982; Fasano et al., 1986) . Mostly they owe their transforming properties to single point mutations within their coding region (Reddy et al., 1982; Tabin et al., 1982; Taparowsky et al., 1982) . However, in some cases, alteration of the regulatory sequences of the gene may also induce its transforming activity as uncontrolled expression of such gene products could be expected to alter the fate and growth potential of cells (Theillet et al., 1986) .
Increasingly, evidence suggests that 10-to 100-fold amplification of non-mutated ras genes can induce certain manifestations of the malignant phenotype . In several significant tumour types [breast (Hand et al., 1984) , colon (Gallick et al., 1985) , gastric (Bos et al., 1986) , glial (Blin et al., 1987) , lung and bladder cancers (De-Biasi et al., 1989) ] elevated levels of normal Ras protein may well be crucial to tumorigenesis (Tanaka et al., 1986) . It has also been shown that high levels of ras product can lead to transformation of certain recipient cell types . It seems, therefore, that a combination of qualitative and quantitative alterations within ras genes is capable of inducing a more complete spectrum of neoplastic phenotypes.
Ras and Ras-related proteins have been highly conserved in diverse living systems, and share similar structural and biochemical properties (Barbacid, 1987; Chardin, 1988; Dhar et al., 1984; Neuman-Silberberg et al., 1984; Reymond et al., 1984) . In Drosophila melanogaster, cellular genes related to several viral oncogenes have been detected (Liven et al., 1985; Shilo, 1987 , Wadsworth et al., 1985 . Three ras genes have been isolated and termed rasi, ras2 and ras3. These genes have been mapped to loci 85D, 64B and 62B respectively, on the polytene chromosomes of larval salivary glands (Neuman-Silberberg et al., 1984) . They share on average 80% similarity with vertebrate ras p21 proteins at their N-terminus (Brock, 1987; Mozer et al., 1985; NeumanSilberberg et al., 1984) . Structural homologies between the Drosophila and vertebrate Ras proteins were demonstrated by precipitating 21 kDa and 27-28 kDa proteins from Drosophila cell extract using monoclonal antibodies raised against the v-Ha-ras p21 protein (Papageorge et al., 1984) . At the functional level, it has previously been shown that ras chimeric genes derived from Drosophila can promote neoplastic transformation of mammalian cells (Schejter & Shilo, 1985) . Recently, results show that Ras3 disrupts normal cell fate specification in the photoreceptor cells in the Drosophila developing eye (Hariharan et al., 1991) , while Ras 1 has been shown to participate in the transmission of signals involved with this process (Rubin, 1991) . The analogues in the mammalian system, rapl/Krev (ras3 homologues), have been shown to suppress the transforming activity of the human Ki-ras oncogene (Kitayama et al., 1989) .
The Drosophila ras2 proto-oncogene is regulated by a bidirectional promoter, as are the human c-Ha-rasl and the mouse c-Ki-ras genes (Hoffman et al., 1987; Spandidos & Riggio, 1986) , but in the last two cases no specific opposite transcribing gene has yet been identified. A distinct transcription unit, which was termed rop (for ras opposite), has been located only 94 bases upstream of the Drosophila ras2 gene, and it seems that the ras2/rop promoter is one of the shortest bidirectional promoters identified so far (Cohen et al., 1988) . Studies of the spatial distribution of the mRNA transcribed from the two genes during development produced almost identical patterns. Both genes are transcribed -in oocytes, while in early embryos mRNA distribution is localised mostly in the peripheral nervous system (Lev et al., 1985; Segal & Shilo, 1986; Salzberg et al., 1993) . Analysis of the rop product revealed a 68 kDa non-nuclear protein situated in both the membranous and the cytosolic subfractions (Salzberg et al., 1993). ras2/rop BIDIRECTIONAL EXPRESSION IN DROSOPHILA 265 Precise characterisation of the entire transcriptional mechanism controlling the expression of both genes may be one approach to determine whether the rop gene product can interact with the Ras protein in any way during signal transduction. Identification of the DNA elements and protein factors regulating the genes would provide some insight into the various signals which might select for the induction of one gene and others capable of inducing/repressing the simultaneous expression of both genes. Furthermore, a comparison of the conserved cis elements regulating the human ras genes and the Drosophila ras2 gene should facilitate detailed understanding of how specific factors can modulate ras overexpression, and hence tumorigenesis.
In this paper we show that the ras2/rop bidirectional promoter supports the transcription of both genes. This is probably achieved by one unitary complex and not by two separate transcription complexes regulating each gene. Mobility-shift assays indicate the binding of a single major protein complex to the ras2lrop promoter. Evidence for the interaction of two different factors (components of this main protein complex), with a CACCC box-containing region and another promoter fragment, which carries different overlapping motifs, has been obtained by competition experiments, partial purification of nuclear extract and DNAse I footprinting analysis. The regions demarcated by these sequence classes have been found necessary for maximal transcription in both directions. In addition, it appears that by supplementing the cells with different serum components DNA-binding specificity can be altered.
Materials and methods

Plasmid constructions
The Drosophila ras2 promoter and part of the downstream non-translated region were linked to the bacterial chloramphenicol acetyl transferase (CAT) gene in the promoterless vector p106 (a derivative of pSVOCAT; Gorman et al., 1982) . The same was done for the rop gene flanking the other side of the promoter. The two constructs have been named pRAS-CAT and pROP-CAT respectively. By introducing progressive deletions into sequences upstream of the ras2 or the rop transcription start sites, the following plasmids were constructed: pRASO-CAT, pRAS1-CAT, pRAS2-CAT, pRAS9-CAT, pRASl 1-CAT, pROPl-CAT, pROP4-CAT, pROP5-CAT, pROP6-CAT, pROP7-CAT and pROP8-CAT. The precise sites of deletions as determined by sequencing are illustrated in Figure 6 .
Oligonucleotides
The oligonucleotides (oligos) containing the different consensus DNA-binding sequences or promoter elements were chemically synthesised. Double-stranded oligos were used as competitors and probes in the gel retardation assays. The sequences of the sense strand of the oligos used were: RR1 (for right repeat of fragment I), 5'-CGCCCGTCTCAGTGC-GAGT-3'; FRI (for fragment I), 5'-CGATCTAGCAGAGA-CGCGCACCCGTCTCAGTGCGAGAGATCTG-3'; Fim (for fragment I mutant), 5'-CGATCTAGCAGAGACGCGCAC-TTGTCTC AGTGCGAGAGATCTG-3'; FR2 (for fragment II), 5'-CGATCGTCTCAGTGCGAGTGTGGATTT CTCA-GTTAACCGAGAA-3'; AP-1 (for AP-1 consensus sequence), 5'-CGATGAGTCAGATGAGTCAGT-3'; AP-Im (for AP-1 mutant), 5'-CGATGAGGTAGATGAGGTAGT-3'; TAT (for TATA-like promoter sequence), 5'-CTAGGATATCGATAT-TACTGTCTA-3'; and control sequence, 5'-AAGGCTACA-CTGTTAATTTT-3'.
DNA transfection
Plasmids used for transfection were purified through a caesium chloride gradient (Maniatis et al., 1989) . For transfection, 3 Zg of plasmid DNA was transfected into Drosophila Schneider 2 (S2) cells (Schneider, 1972) by the standard calcium phosphate procedure described by Quinones et al. (1989) . After 48 h in medium containing 10% fetal calf serum (FCS, Highveld Biological) or fetal bovine serum (FBS, Delta Bioproducts), the cells were harvested as described by Gorman et al. (1982) .
CA T assay CAT activity was measured by assaying percentage incorporation of ['4C]acetyl coenzyme A (CoA) into chloramphenicol by the one-vial assay as described by Sleigh (1986) . All assays were performed in the linear range and equal amounts of protein were used for each sample. Each plasmid, from at least two different plasmid preparations, was tested 3-5 times. The copy number of transfected plasmids was normalised by slot-blot hybridisation. Although we observed that the magnitude of induction may vary from one batch of cells to the next, the relative activities of each of the constructs remained constant.
Fractionation of the S2 nuclear extract The Drosophila nuclear extract was prepared from logarithmically growing S2 cells essentially as described by Dignam et al. (1983) . The buffer used in all chromatographic steps was buffer C (20 mM HEPES pH 7.9, 20 mm potassium chloride, 1.5 mM magnesium chloride, 25% glycerol, 0.2 mM EDTA, 1 mM DTT and 0.5 mM phenylmethylsulphonyl fluoride). Heparin-agarose was purchased from Bio-Rad and phosphocellulose was kindly provided by V. Mizrahi, SAIMR. Typically, 5 mg of S2 nuclear extract was loaded on 3 ml heparin-agarose or phosphocellulose columns equilibrated with buffer C, followed by elution with a sodium chloride gradient (100-1,000 mM). Fractions were collected, concentrated and dialysed against buffer C. Small aliquots of all protein fractions were frozen in liquid nitrogen and stored at -70°C.
Band mobility-shift assays Gel retardation assays (Xiao et al., 1987) were performed using 20 jil reactions containing nuclear extract or chromatographic fractions with 0.05-2 ytg of poly(dI-dC) (Sigma) and 0.8 ng of 32P-labelled DNA probes (approximately 30,000 counts per min, prepared using the Klenow fragment of DNA polymerase I or polynucleotide kinase). The reactions containing buffer C were incubated in the presence or absence of a 10-, 20-or 40-fold molar excess of unlabelled DNA competitors as described in the text. The unbound free probes were resolved from the DNA-protein complexes by electrophoresis through a 5-6% (29:1) non-denaturing acrylamide gel in a buffer containing 45 mM Tris base, 45 mM boric acid and 1 mM EDTA (pH 8.5) (Ryan et al., 1989) . The gels were then dried and exposed to Fuji X-ray film at room temperature for approximately 24 h. DNAse Ifootprinting DNAse I protection assays were performed according to Davidson et al. (1986) using the heparin-agarose column fractions. The probe used was a 320 bp labelled fragment containing the entire ras2/rop promoter and flanking regions.
Digestion with DNAse I (3 1g ml-') was performed at 20°C for 90s. The G+ A reaction was done as described by Maxam and Gilbert (1980) .
Results
One main protein complex binds the ras2/rop bidirectional promoter To identify the nuclear protein complexes regulating the bidirectional expression of the ras2/rop constructs, we deter-mined the ability of several promoter fragments to bind transcription factors using gel-shift experiments and DNAse I protection assays. Nuclear extracts were obtained from Schneider 2 tissue culture cells (S2) and 12h embryos, in which the promoter is similarly active in both directions. Labelled restriction fragments from the promoter region were incubated with nuclear extracts in the presence of poly(dI-dC) to prevent 'non-specific' protein-DNA interactions. The resulting complexes were separated by electrophoresis ( Figure  1 ). Incubation of the entire promoter region with Drosophila embryo nuclear extract (unpublished data), or S2 cell nuclear extract, generated a primary retarded complex of relatively high molecular weight, hereafter referred to as 'complex M' (Figure la) . Similarly, probing with a 59 nt sequence upstream of the ras2 cap site identified the same retarded complex M (Figure lb ). An additional feature of these determinations was the appearance, in certain of the nuclear extracts, of two other factors with lower molecular weight (see Figure 2a , lanes 1-4). For future reference these two factors are denoted 'A' and 'B'. Recent experiments involving further purification of the factors A and B have shown that together they occupy the same sites as complex M within the ras2/rop bidirectional promoter (see below and unpublished data). It would appear, therefore, that complex M functions as a unit consisting of a number of constituent factors.
Determination of specific protein binding sites
To identify the sequence specificity of the binding activity, heparin-Ultragel fractions were subjected to DNAse I footprinting experiments. Double-stranded DNA containing the ras2/rop promoter region was end labelled with 32P at position -117 and used as the probe (see Figure 7 ). Following incubation with the various fractions the probe DNA was subjected to partial cleavage with pancreatic DNAse I. Reaction with increasing amounts of the H.3 (300 mM) fraction Figure 3d ). As is indicated, DNAse I protection of region B was inhibited exclusively by fragment I, while the AP-1 consensus sequence site could not abolish complex formation (Figure 4d ). These DNAse I protected regions are specific, behaving in a dose-dependent manner when subjected to competition assays (Figure 3c) . A remarkable discovery is that inducing the cells with different sera confers different DNA-binding specificites dependent on the type of serum used. As the sera were purchased from different sources we are presently unsure of the specific components affecting the observed alteration in DNA-binding affinity. The three were a double-stranded specific binding protein B and two non-specific single-stranded binding proteins. These results were confirmed using a second probe, RR1, consisting of a 14 bp segment of FRI (Figure 2b ). The smaller DNA-protein complex, complex B, behaves like a typical double-strand-specific binding protein as addition of 10-to 40-fold excess of identical unlabelled oligomers successfully competes for the formation of this protein complex. Making use of a 19 bp fragment overlapping region A (-58 to -39, Figure 7 ), referred to as the TAT oligomer, an additional three distinct factors were identified: a small protein-DNA complex, complex A, which can only be inhibited efficiently with the double-stranded TAT oligomer, and two distinct but larger protein factors that bind nonspecifically to single-stranded DNA (Figure 2a , lane 6, and unpublished data).
Therefore, making use primarily of the two oligomers TAT and FRI we provide strong evidence for the binding of two specific factors, A and B, to two adjacent sites in the central region of the promoter.
Partial purification of the trans-binding factors The major protein complex M was partially purified by chromatography on heparin-Ultragel or phosphocellulose columns and the various fractions eluted used in mobilityshift assays (see Figure 4) . It is important to note that all reactions employed equal amounts of protein. entire labelled promoter region as a probe, the majority of complex M was eluted in the 300 mM sodium chloride fraction of the type of column used (results not shown). This represented an approximate 40-fold purification with respect to the crude nuclear cell extract. Gel retardation assays identified a number of factors using fractions from the heparin-Ultragel column and a 32P-labelled RRI fragment corresponding to region B. The 400 mM sodium chloride fraction primarily contained the relatively low molecular weight factor described as B above. The 200 mM sodium chloride fraction did not show any specific binding activity despite the presence of a higher molecular weight complex. The 300mM sodium chloride eluate, however, showed the presence of both the low molecular weight double-stranded specific factor B and the larger protein-DNA complex with a higher molecular weight, probably corresponding to complex M above (Figure 4a and b) . Interestingly, combining aliquots of the 200 mM and 400 mM sodium chloride fractions resulted in the enhancement of the larger complex M with the concomitant reduction in the intensity of complex B (Figure 4c ).
Taken together, these results suggest the formation of a heterodimer through the direct interaction between factor B and another protein factor not capable of interacting directly with RRI. This latter factor, factor A, is present in the 200mM and 30011M samples and contributes to the formation of the larger complex M seen when either RR1 or the entire promoter region is used as a probe (unpublished data). Moreover, the complexes were sequence specific since they are greatly reduced when equivalent unlabelled promoter elements were added to the reaction (see Figure 4b for example).
Serum specificity To investigate whether protein-DNA binding properties could be altered by changing serum conditions only, nuclear extracts from cells supplemented with either FBS or FCS were examined by gel mobility-shift experiments. A series of deletions of the ras2/rop promoter used as competitors identified two regions as being necessary for binding to occur. Employing nuclear extracts from S2 cells induced with FBS, or 12 h embryos, the right central region of the promoter (-32 to 1 overlapping region B, Figure 7 ) was shown to bind the large protein complex, complex M. This is illustrated in Figure Sa and b, in which the three different competitors G, H and I (representing a 63 bp fragment -95 to -32) were unable to block complex formation. Furthermore, CAT expression assays showed that the same region of DNA gave the highest levels of promoter activity in transfected FBS-supplemented cells and injected embryos (see below).
Cells exposed to FCS, however, showed that the same large protein complex M binds the left central region of the promoter -70 to -47 (Figure 5c ). This is evident from the combined results of competitors C and G, which account for the regions between -95 and -70 and also between -47 and 1, which were unable to block the formation of complex M.
The results presented here indicate the presence of one main protein complex, complex M, capable of interacting with the central promoter region and thus regulating the expression of both genes. Corresponding to the DNAse I protection analysis, alteration of serum components presumably modifies the relative DNA-binding specificity of the two constituent proteins of this complex. This could be the result of subtle differences in any number of factors constituting the two sera. ras2/rop promoter activity A series of constructs of the Drosophila ras2/rop promoter with specific deletions was tested for possible regulatory roles in the presence of either FBS or FCS. The fortuitous differences in binding activity between FBS-and FCSsupplemented cells proved to be a useful assay permitting us to select for two distinct DNA-protein binding events. Each reporter plasmid contained part of the ras2/rop promoter as well as the 5' non-translated regions of ras2 or rop, joined to the Escherichia coli chloramphenicol acetyl transferase (CAT) gene (Figure 6 , see Materials and methods for details). The promoterless plasmid p106 (see Materials and methods) was introduced as the control. All plasmids were transfected into Drosophila S2 cells grown in the presence of either 10% FCS or 10% FBS. CAT activity was assayed 48 h later. It is important to note that DNA concentration was normalised after transfection using slot-blot analysis.
The compositions of the various deletions and their relative promoter activities in the transient expression assay are shown in Figure 6a tions of the promoter region (constructs pRASI-CAT, -85 to -24; and pRASO-CAT, -74 to -5) showed levels of ras2-CAT expression below 10%. Deletion of the right region of the promoter in the ROP-CAT set of plasmids (-32 to 32, pROP6-CAT) resulted in 65% decrease in rop-CAT expression. Further deletions of the central region (plasmids pROP5-CAT, -52 to 1; pROP4-CAT, -70 to 1; and pROPl-CAT, -86 to -15) led to drastically diminished rop-CAT expression. Combined, these deletion data suggest that approximately 32 bp (-47 to -15) are essential for transcription efficiency of at least 60%, in both directions, in the presence of FBS. Two features worth noting in the nucleotide sequence in this region are (i) the presence of an AP-l-like sequence and (ii) a perfect CACCC consensus sequence in the centre of a hairpin structure (Figure 7) .
Transfecting S2 cells, grown in the presence of FCS, with these same constructs produced noticeably different results (Figure 6a and b) . Paralleling the above, pROPI-CAT and pROP4-CAT, together accounting for the regions between -95 and -70 and between -15 and 32, contribute to not more than 3% promoter activity. Fifty to sixty per cent of ROP-CAT expression was achieved by introducing pROP6-CAT (representing the region between -95 and -32), while removal of a region between -118 and -47 (pRAS2-CAT) resulted in a 60-70% decrease in RAS2-CAT expression. In addition, results obtained with pRASO-CAT and pRASI-CAT which extend from -118 to -74 and -24 to 1 demonstrate promoter activity of less than 5%. Together, these data support the conclusion that in the presence of FCS the promoter activity, although focused at the centre of the bidirectional promoter as above (-70 to -15) , is shifted slightly upstream (graphically represented in Figure 6c ). With FBS as the supplement the region between -47 and -15 (see constructs pRAS1-CAT, pRAS2-CAT, pROP1-CAT and pROP6-CAT) contributes to approximately 60% of promoter activity. In contrast, this same region contributes not more than 40% using nucelar extract of cells grown in FCSsupplemented medium. Further, the region between -70 and -32 (see constructs pRASO-CAT, pRAS2-CAT, pROP4-CAT and pROP6-CAT) supports 50-60% of the bidirectional expression in the presence of FCS, but only 30-40% when FBS is added.
A point worth noting is that injecting Drosophila embryos with the same constructs produced almost identical results as those obtained with the FBS-supplemented cells (unpublished data). It therefore appears that different serum conditions can alter the specificity of DNA-protein binding interactions and as a result affect gene regulation. As mentioned previously, the precise nature of the relative differences between the two sera is not well understood, but preliminary results indicate that differences in salt concentration may play a role in this regard.
Closer examination of the left central region revealed different overlapping sequence motifs, some of which exhibnit homology to known consensus elements, that is a TATAlike element; a sequence which shares 85% homology with the dyad symmetry element (CCArGG box -the core sequence of the serum response element); DRE -an octamer representing an element found upstream of two DNA replication-related genes; and a 5 bp GATA sequence (GATAT/G) repeated seven times.
Discussion
Integrated into the functional network of oncoproteins must be mechanisms for the mutual regulation of oncogene expression, since the dose and activity of each member of the network need to be tightly controlled. Since none of the cellular factors is constitutively active, there is always the possibility that oncogenicity results from an altered response to regulation.
In this article we have presented structural and functional evidence suggesting that the two genes flanking the bidirectional promoter (ras2 and rop) are regulated by a single protein complex (complex M promoter, which employs the identical enhancer within the first intron of the xl(IV) gene for efficient transcriptional activity (Burbelo et al., 1988) . Separate transcriptional mechanisms also occur, an example being the bidirectional promoter of the his3 and petS6 genes in yeast. Among the trans factors interacting with this promoter, the GCN4 activator can induce his3 expression but not pet56 expression in the opposite direction (Struhl, 1987) . In this context it should be noted that several gene pairs regulated by bidirectional promoters are ubiquitously expressed [the mouse DHFR gene and small nuclear RNAs ; the Drosophila tl and t2 genes (Swaroop et al., 1986) ; and the mouse surf-1 and surf-2 genes (Williams & Fried, 1986) ].
A possible regulatory interaction between the ras2 and rop products has been proposed by Salzberg et al. (1993) . The expression patterns of these two genes is almost identical in a given tissue. rop is simultaneously expressed with ras2 in oocytes and the peripheral nervous system of Drosophila embryos. rop (but not ras2) is also present in the embryonic central nervous system. In the larva, ras and rop activity is limited to specific sites within the ventral ganglion and the brain hemispheres. In the adult, transcripts are found in the legs, wings and specific nerve cells of the brain (Salzberg et al., 1993) . Taken together, these findings suggest a possible interaction between the two gene products in both undifferentiated proliferating cells and terminally differentiated tissues.
Vertebrate ras promoters are generally GC rich, do not contain the consensus sequences directing polymerase II transcription such as the TATA box, but do contain a number of GC boxes (Hall & These features are very similar to those of the human EGF receptor promoter (Ishii et al., 1985b) and to those of a number of cellular housekeeping gene promoters [e.g. HMG coenzyme A reductase (Osborne et al., 1985) ; mouse and human DHFR Masters & Atgardi, 1985) ; human superoxide dismutase (Levanon, 1985) ]. In the human c-Ha-rasl promoter region, multiple elements are required for transcriptional control. Among them are the Spl-binding sites, a CCAAT box element and a CACCC box element (also found in globin gene promoters), which are necessary for maximal promoter activity (Lowndes et al., 1989; Takahiro et al., 1990) . The Drosophila ras2 promoter region shares a conserved CACCC element with the human c-Ha-rasl promoter. This motif lies in a stretch of imperfect palindrome and has the potential to form cruciform structures containing mismatched base pairs. This is common to many genes that harbour CREs in their promoter region and are induced by cAMP (McMurray et al., 1991) . In this instance, it is possible that formation of cruciform structures may be a general feature of certain classes of cis elements. One of the components of the main protein complex described here, factor B, has been found to interact with a promoter region spanning the CACCC element. This element has previously been shown to bind the general transcription factor Spl (Yu et al., 1991) . As Drosophila cells seem to lack homologues of this binding protein (Santoro et al., 1988) , mutational analysis, competition experiments and affinity purification of this binding factor will indicate which factor can bind this element in Drosophila cells. Without knowledge of the precise mechanisms of transcription initiation of TATA-less promoters, it has been suggested that in these promoters containing CACCC or Spl binding sites transcription factors can substitute for TFIID function to initiate transcription (Tamura & Katsuhiko, 1991) .
The second component of the major complex, the A-region binding factor (factor A), alone interacted very poorly with the promoter region. However, by forming a heterodimer with the B factor, binding efficiency to the A region is enhanced. To date there are reports of many transcription factors that bind to DNA as dimers of either homomeric or heteromeric composition. It may be that heterodimers have sequence specificities different from either of the individual constituents (Hunter, 1991; Jones, 1990; Lewin, 1991) .
The TATA-like sequence within region A may serve to identify both the sense strand and the precise transcription start point for the rop gene. Two DNA replication-related genes, the proliferating cell nuclear antigen (PCNA) and the Drosophila DNA polymerase, have been found to contain an 8 bp promoter element TATCGATA-DRE in their regulatory region (Yamaguchi et al., 1991) . Strikingly, there is complete homology (100%) between this regulatory element and region A. If the DRE motif plays a role in the regulation of ras2 expression it might be that DNA replication-related genes are final targets of the ras signal pathway and hence may all be regulated by a common mechanism.
An initiator element present at the ras2 transcription start site, the cap box, has been found in approximately 60% of all promoters (Bucher, 1990 ). This element has been shown to be non-essential for promoter activity in certain cases (Grosschedl & Birnstiel, 1980) , but a prerequisite for transcription of other genes (Arkhipova & Ilyin, 1991) . The positional distribution of this element shows striking congruency between vertebrate and non-vertebrate promoters. The obvious candidates for binding to this weak cap signal are RNA polymerase II and transcription factor TFIID (Nakajima, 1988) . No protein binding was observed to the cap box repeats in the vicinity of the ras2 transcription start site. Furthermore no essential promoter activity could be identified solely in the presence of this cap box element.
Of interest is the observation that altered DNA-protein binding specificities can be achieved by supplementing the growth media with different sera. Observations from different systems have shown that hormone binding can induce a conformational change in the oestrogen receptor, which leads to an increased affinity for DNA (McGrogan et al., 1985; Skafar & Notides, 1985) , while HBV X protein can alter the DNA-binding specificity of CREB and ATF-2 by protein-protein interactions (Maguire et al., 1991) . The precise effect of any given factor is determined by a variety of elements, such as cell type, concentration of factor and the duration of the stimulus, with the result that certain growth factors may fulfil quite different functions under different circumstances. Changing serum conditions might cause modifications in enzymes that act upon such elements, which in turn may influence the regulatory machinery. The above demonstration of serum-specific changes might mean that region A mediates transcriptional activation under certain conditions through serum stimulation. It is well known that serum induction of cell division requires ras protein and possibly ras expression, based on the fact that the levels of transcription of several other proto-oncogenes are increased soon after serum addition (Gauthier-Rouviere et al., 1990; Mulcahy et al., 1985) . The ras protein may, therefore, represent a common element in the molecular cascade of events initiated by numerous growth factors referred to as serum components.
Since the ras genes are a ubiquitous gene family and likely to play a fundamental role in normal cellular function based on their high degree of conservation throughout eukaryotic evolution, it is not unexpected that their regulatory mechanisms may have been conserved to some degree as well. 
